EUVIMEDEUVIMED entdecken
Crossref

A synthetic resveratrol–curcumin hybrid derivative exhibits chemopreventive effects on colon pre-neoplastic lesions by targeting Wnt/β-catenin signaling, anti-inflammatory and antioxidant pathways

Mariane Minussi Baptistella, Raphaela Rebeca Silveira Assunção, Carolina Sales de Oliveira, Aléxia Polo Siqueira, Elda Gonçalves Dos Santos, Matheus de Freitas Silva, Ellen Tardelli Faleiros Lima, Ester Siqueira Caixeta, Rômulo Dias Novaes, Eric Batista Ferreira, Marisa Ionta, Claudio Viegas und 1 weitere

Journal of Pharmacy and Pharmacology · 01.05.2024 · 76 (5) · 479-488

DOI: 10.1093/jpp/rgad077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 01.05.2024. Verfasst von Mariane Minussi Baptistella und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Natural Sciences, Federal University of Alfenas, 37130-000, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Curcumin, Resveratrol, Rats, Wistar, Wnt Signaling Pathway. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Based on the effectiveness of resveratrol and curcumin in carcinogenesis, (E)-3-(4-hydroxy-3-methoxyphenyl)-Nʹ-((E)-4-methoxybenzylidene) acrylohydrazide (PQM-162), curcumin–resveratrol hybrid derivative, was designed by molecular hybridization using a hydrazone functionality as a spacer moiety between pharmacophoric fragments inspired by the parent compounds.

Objectives

The present study aimed to evaluate the chemopreventive effects of the hybrid against pre-neoplastic lesions induced in the colon of rodents.

Methods

The doses were determined based on the reduction in DNA damage induced by doxorubicin [15 mg/kg body weight (b.w.)] in peripheral blood of Swiss mice. Doses of 8, 16, 32, and 64 mg/kg b.w. were antimutagenic. For the evaluation of pre-neoplastic lesions in the colon, Wistar rats were treated with PQM-162 at doses of 0.5, 1, and 2 mg/kg b.w. for 6 weeks using three approaches: simultaneous treatment, pre-treatment, and post-treatment. Pre-neoplastic lesions were induced with 1,2 dimethylhydrazine (160 mg/kg b.w.). Key findings PQM-162 reduced the formation of aberrant crypt foci in the simultaneous treatment and post-treatment. TNF-α and COX-2 mRNA levels decreased, while Nrf2 mRNA levels increased. PQM-162 also reduced the expression of COX-2, PCNA, and β-catenin protein markers and increased Nrf2 expression.

Conclusion

Our findings suggest a chemopreventive potential of PQM-162 in colorectal carcinogenesis, which acts on anti-inflammatory, antioxidant, and cell proliferation pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminResveratrolRats, WistarWnt Signaling PathwayAntioxidantsAnti-Inflammatory AgentsAnimalsMiceMaleRatsColonic NeoplasmsColonPrecancerous ConditionsNF-E2-Related Factor 2beta CateninAnticarcinogenic AgentsCyclooxygenase 2StilbenesDNA Damage1,2-DimethylhydrazineDoxorubicinCell ProliferationDose-Response Relationship, Drug

Stichwörter der Autor:innen

COX-2Nrf2PCNAPQM-162aberrant crypt focicolorectal cancer

Substanzen

CurcuminResveratrolAntioxidantsAnti-Inflammatory AgentsNF-E2-Related Factor 2beta CateninAnticarcinogenic AgentsCyclooxygenase 2Stilbenes1,2-Dimethylhydrazine

Autor:innen und Institutionen

  • Institute of Natural Sciences, Federal University of Alfenas, 37130-000, Minas Gerais, Brazil.
  • Institute of Biomedical Sciences, Federal University of Alfenas, 37130-000, Minas Gerais, Brazil.
  • Institute of Chemistry, Laboratory of Research in Medicinal Chemistry, Federal University of Alfenas, 37133-840, Minas Gerais, Brazil.
  • Institute of Exact Sciences, Federal University of Alfenas, 37130-000, Minas Gerais, Brazil.

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Zitieren

APA

Baptistella, M. M., Assunção, R. R. S., Sales de Oliveira, C., Siqueira, A. P., Gonçalves Dos Santos, E., de Freitas Silva, M., Lima, E. T. F., Caixeta, E. S., Novaes, R. D., Ferreira, E. B., Ionta, M., Viegas, C., & Francielli de Oliveira, P. (2024). A synthetic resveratrol–curcumin hybrid derivative exhibits chemopreventive effects on colon pre-neoplastic lesions by targeting Wnt/β-catenin signaling, anti-inflammatory and antioxidant pathways. Journal of Pharmacy and Pharmacology, 76(5), 479-488. https://doi.org/10.1093/jpp/rgad077

Vancouver

Baptistella MM, Assunção RRS, Sales de Oliveira C, Siqueira AP, Gonçalves Dos Santos E, de Freitas Silva M, et al. A synthetic resveratrol–curcumin hybrid derivative exhibits chemopreventive effects on colon pre-neoplastic lesions by targeting Wnt/β-catenin signaling, anti-inflammatory and antioxidant pathways. Journal of Pharmacy and Pharmacology. 2024;76(5):479-488. doi:10.1093/jpp/rgad077

BibTeX
@article{Baptistella2024,
  author = {Baptistella, Mariane Minussi and Assunção, Raphaela Rebeca Silveira and Sales de Oliveira, Carolina and Siqueira, Aléxia Polo and Gonçalves Dos Santos, Elda and de Freitas Silva, Matheus and Lima, Ellen Tardelli Faleiros and Caixeta, Ester Siqueira and Novaes, Rômulo Dias and Ferreira, Eric Batista and Ionta, Marisa and Viegas, Claudio and Francielli de Oliveira, Pollyanna},
  title = {A synthetic resveratrol–curcumin hybrid derivative exhibits chemopreventive effects on colon pre-neoplastic lesions by targeting Wnt/β-catenin signaling, anti-inflammatory and antioxidant pathways},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2024},
  volume = {76},
  number = {5},
  pages = {479--488},
  doi = {10.1093/jpp/rgad077}
}
Kostenlos starten →